XGen Pharmaceuticals Competitors and Similar CompaniesClear all

XGen Pharmaceuticals's competitors and similar companies include PLx Pharma, Genentech, Cipla and Mankind Pharma.

	XGen Pharmaceuticals XGen Pharmaceuticals DJB is a company that specializes in drug development.	PLx Pharma PLx Pharma is a specialty pharmaceutical company focused on its clinically-validated PLxGuard drug delivery platform.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.
Founding Date	Founding Date 2003	Founding Date 2002	Founding Date 1976	Founding Date 1935	Founding Date 1995
Type	Type Private	Type Public	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Horseheads, US HQ	Locations Sparta, US HQ Houston, US Woodmere, US	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations New Delhi, IN HQ
Employees	Employees 632% increase	Employees 16100% increase	Employees 18,077	Employees 27,764	Employees 16,2532% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $8.2m (FY, 2021)	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $4.8m (FY, 2021)	Cost of goods N/A	Cost of goods ₹95.5b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $3.4m (FY, 2021)	Gross profit N/A	Gross profit ₹195b (FY, 2026)	Gross profit N/A
Net income	Net income N/A	Net income ($46.1m) (FY, 2021)	Net income N/A	Net income ₹38.7b (FY, 2026)	Net income N/A